Concepedia

P. L. Kunz

PL

3

Publications

90

Citations

3

H-Index

2008

Active since

P. L. Kunz is an author specializing in cancer therapeutics, oncology, and cancer research.

Top concepts

Publications per year

2008–2010

3

Publications

3

A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors.

P. L. Kunz, Tzu‐Ting Kuo, Jeffrey Zahn et al. · Journal of Clinical Oncology · 2010 · 47 citations

, , +14

A phase II study of capecitabine, oxaliplatin, and bevacizumab for metastatic or unresectable neuroendocrine tumors: Preliminary results

P. L. Kunz, Tzu‐Ting Kuo, H. L. Kaiser et al. · Journal of Clinical Oncology · 2008 · 30 citations

, , +18

Phase I trial of preoperative cetuximab in combination with oxaliplatin, capecitabine, and radiation therapy for locally advanced rectal cancer

Elwyn C. Cabebe, Tzu‐Ting Kuo, Albert C. Koong et al. · Journal of Clinical Oncology · 2008 · 13 citations

, , +14

Rows per page

1–3 of 3